Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer.
Jun ImaizumiDai ShidaNarikazu BokuHiroshi IgakiJun ItamiYasuji MiyakitaYoshitaka NaritaAtsuo TakashimaYukihide KanemitsuPublished in: International journal of clinical oncology (2023)
Overall survival of patients with BMs from CRC improved since 2014, which can be attributed to advances in chemotherapy and the more widespread use of stereotactic radiotherapy.